Exact Mass: 345.2012092
Exact Mass Matches: 345.2012092
Found 500 metabolites which its exact mass value is equals to given mass value 345.2012092,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Murrayacinine
Murrayacinine is found in herbs and spices. Murrayacinine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree
Rosmaricine
C20H27NO4 (345.19399820000007)
Rosmaricine is found in herbs and spices. Rosmaricine is isolated from rosemary (Rosmarinus officinalis) using NH3 during extraction. Isolated from rosemary (Rosmarinus officinalis) using NH3 during extraction. Rosmaricine is found in herbs and spices and rosemary.
Bevantolol
C20H27NO4 (345.19399820000007)
Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension. Mechanism of Action Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Sebacoyl-L-carnitine
C17H31NO6 (345.21512659999996)
Sebacoyl-L-carnitine is an acylcarnitine. More specifically, it is an sebacic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Sebacoyl-L-carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Sebacoyl-L-carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3-Methylnonanedioylcarnitine
C17H31NO6 (345.21512659999996)
3-Methylnonanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-methylnonanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylnonanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylnonanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane
C19H23NO5 (345.15761480000003)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Cyclofoxy
C20H24FNO3 (345.17401259999997)
4-[[4-Amino-6-(2,4,6-trimethylanilino)-1,3,5-triazin-2-yl]amino]benzonitrile
2-[4-[4-(4-Carbamimidoylphenyl)piperazin-1-yl]piperidin-1-yl]acetic acid
C18H27N5O2 (345.21646419999996)
Inolin
C19H23NO5 (345.15761480000003)
L-Arginine, L-asparaginylglycyl-
4-Phenyl-1-(3-(tetrahydro-2-furyl)propyl)isonipecotic acid ethyl ester
4-Tert-butyl-2-[(tert-butylamino)methyl]-6-(4-chlorophenyl)phenol
C21H28ClNO (345.18593080000005)
(E)-(4-Hydroxy-3-methoxycinnamoyl)epilupinine
C20H27NO4 (345.19399820000007)
(1-(3-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
C21H28ClNO (345.18593080000005)
(1-(4-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
C21H28ClNO (345.18593080000005)
(1-(2-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
C21H28ClNO (345.18593080000005)
N-Desmethyl-8??-ethoxy pretazettine
C19H23NO5 (345.15761480000003)
(2E)-11-(4-aminophenyl)-5,9-O-cyclo-4,6,8-trimethyl-11-oxo-undec-2-enoic acid
C20H27NO4 (345.19399820000007)
2,13-dimethoxy-13,16-cyclo-12,16-seco-kesselringan-11-ol|5,6a-dimethoxy-1-methyl-1,2,3,7,8,9,10,11,12,12a-decahydro-6aH-benzo[4,5]furo[4,3,2:4,5]naphtho[1,8-bc]pyridin-8-ol|Luteicin|luteicine
C20H27NO4 (345.19399820000007)
Holidinine|robustinine|Robustivine
C20H27NO4 (345.19399820000007)
10beta-Hydroxy-3,4-dimethoxy-17-methyl-hasubanan-7,8-dion|10beta-hydroxy-3,4-dimethoxy-17-methyl-hasubanan-7,8-dione
C19H23NO5 (345.15761480000003)
alpha-N-acetyl-indole-3-acetyl-epsilon-L-lysine|N-alpha-Acetyl-N-epsilon-(indole-3-acetyl)-L-lysine
C18H23N3O4 (345.16884780000004)
3alpha,6alpha,7-trimethoxy-crin-1-ene|6-Methoxybuphanidrin|6alpha-methoxy-buphanidrine|6alpha-methoxybuphanidrine
C19H23NO5 (345.15761480000003)
N-2-(3,4,5-trimethoxyphenyl)ethyl-2-hydroxybenzamide
C19H23NO5 (345.15761480000003)
7-O-Aethyl-lycorenin|7alpha-ethoxy-9,10-dimethoxy-1-methyl-lycoran-4(12)-ene|O-ethyl-lycorenine|O-ethyllycorenine
C20H27NO4 (345.19399820000007)
4,5-epoxy-10-hydroxy-3,6-dimethoxy-17-methyl-morphinan-8-one|Metaphanin
C19H23NO5 (345.15761480000003)
3-(3-methyl-5H-dibenzo[a,d]cyclohepten-5-yloxy)-tropane|5-Tropyloxy-3-methyl-dibenzo-1.3.5-cycloheptatrien|5-Tropyloxy-3-methyldibenzo-1,3,5-cycloheptatrien
20-Oxime-(17alphaOH)-17-Hydroxypregn-4-ene-3,20-dione
(19R)-16beta,19-dihydroxy-(5beta,10alpha)-3-aza-3alpha,19-cyclo-4a-homo-pregnan-21-oic acid 16-lactone|Cycloneosamandaridin
Ala Ala Ala Asn
Ala Ala Gly Lys
Ala Ala Gly Gln
Ala Ala Lys Gly
Ala Ala Asn Ala
Ala Ala Gln Gly
Ala Gly Ala Lys
Ala Gly Ala Gln
Ala Gly Lys Ala
Ala Gly Gln Ala
Ala Lys Ala Gly
Ala Lys Gly Ala
Ala Asn Ala Ala
Ala Gln Ala Gly
Ala Gln Gly Ala
Gly Ala Ala Lys
Gly Ala Ala Gln
Gly Ala Lys Ala
Gly Ala Gln Ala
Gly Gly Asn Val
Gly Gly Val Asn
Gly Lys Ala Ala
Gly Asn Gly Val
Gly Asn Val Gly
Gly Gln Ala Ala
Gly Val Gly Asn
Gly Val Asn Gly
Asn Ala Ala Ala
Asn Gly Gly Val
Asn Gly Val Gly
Asn Val Gly Gly
Gln Ala Ala Gly
Gln Ala Gly Ala
Gln Gly Ala Ala
Val Gly Gly Asn
Val Gly Asn Gly
Val Asn Gly Gly
2- (2,6-DIMETHOXYPHENOXYETHYL)AMINOMETHYL-1,4-BENZODIOXANE (WB 4101)
C19H23NO5 (345.15761480000003)
PF-750
PF 750 is a selective and covalent fatty acid amide hydrolase (FAAH) inhibitor, with IC50s varied from 16.2-595 nM in different pre-incubation times. Covalently modifies the enzyme’s active site serine nucleophile[1].
bevantolol
C20H27NO4 (345.19399820000007)
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Murrayacinine
Rosmaricine
C20H27NO4 (345.19399820000007)
N-jasmonoyl-dopamine
C20H27NO4 (345.19399820000007)
CAR 10:1;O2
C17H31NO6 (345.21512659999996)
(+/-)-PPHT HYDROCHLORIDE (N-0434) POTENT D2 DOPAMINE RE
C21H28ClNO (345.18593080000005)
Tretoquinolum
C19H23NO5 (345.15761480000003)
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
4-[4-(2-phenylethyl)piperidin-1-yl]quinazoline-6-carbaldehyde
tert-butyl 4-(4-amino-2-(trifluoromethyl)phenyl)piperazine-1-carboxylate
TERT-BUTYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)INDOLINE-1-CARBOXYLATE
C19H28BNO4 (345.21112780000004)
1-(3,7-dimethyloctyl)-1-prop-2-enyl-3,4,5,6-tetrahydro-2H-pyridine bro mide
C18H36BrN (345.20309560000004)
2-Azido-1,3-bis[(2,2-dimethyl-1,3-dioxan-5-yl)oxy]propane
METHYL(2S)-2-(BIS(TERT-BUTOXYCARBONYL)AMINO)-5-OXOPENTANOATE
4-(2-Amino-4-trifluoromethyl-phenyl)-piperazine-1-carboxylic acid tert-butyl ester
6-AMINO-3-(4-METHYL-PIPERAZIN-1-YLMETHYL)-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C18H27N5O2 (345.21646419999996)
(2R,3S)-1-CHLORO-3-DIBENZYLAMINO-5-METHYLHEXAN-2-OL
C21H28ClNO (345.18593080000005)
1-Benzyl-N-(tert-butoxycarbonyl)-D-histidine
C18H23N3O4 (345.16884780000004)
TERT-BUTYL 4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE-1-CARBOXYLATE
C18H23N3O4 (345.16884780000004)
2-(4-Boc-piperazinyl)-α-(2-cyano-phenyl)acetic acid
C18H23N3O4 (345.16884780000004)
(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-phenyl-3-propanoyloxypropanoate
C20H27NO4 (345.19399820000007)
2-ETHYLHEXYL ALPHA-CYANO-3,4-DIMETHOXYCINNAMATE
C20H27NO4 (345.19399820000007)
Diphenidol hydrochloride
C21H28ClNO (345.18593080000005)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Diphenidol hydrochloride (Difenidol hydrochloride) is a non-selective muscarinic M1-M4 receptor antagonist, has anti-arrhythmic activity. Diphenidol hydrochloride is also a potent non-specific blocker of voltage-gated ion channels (Na+, K+, and Ca2+) in neuronal cells. Diphenidol hydrochloride can be used in the study of antivertigo and antinausea[1][2][3][4][5].
2-FLUORO-4-[[4-(TRANS-4-PROPYLCYCLOHEXYL)PHENYL]ETHYNYL]CYANOPHENYL
2-dodecylsulfanylcarbothioylsulfanyl-2-methylpropanenitrile
Dibenzyl diisopropylphosphoramidoite
C20H28NO2P (345.18575580000004)
Dicyclomine hydrochloride
C19H36ClNO2 (345.24344260000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent Dicyclomine hydrochloride is a potent and orally active muscarinic cholinergic receptors antagonist. Dicyclomine hydrochloride shows high affinity for muscarinic M1 receptor subtype (Ki=5.1 nM) and M2 receptor subtype (Ki=54.6 nM) in brush-border membrane and basal plasma membranes, respectively[1]. Dicyclomine is an antispasmodic agent and relieves smooth muscle spasm of the gastrointestinal tract in vivo[2].
tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate
C19H28BNO4 (345.21112780000004)
Benzydamine hydrochloride
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D000893 - Anti-Inflammatory Agents
2-ISOBUTOXY-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-5-(TRIFLUOROMETHYL)PYRIDINE
C16H23BF3NO3 (345.17229940000004)
tert-Butyl 4-(1-benzylpyrrolidin-3-yl)piperazine-1-carboxylate
(4R,4aR,7S,7aR,12bS)-3-methyl-1,2,3,4,4a,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7,9-diol,acetate
C19H23NO5 (345.15761480000003)
2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)-2-(3-cyanophenyl)a
C18H23N3O4 (345.16884780000004)
2-(4-BOC-PIPERAZINYL)-2-(4-CYANO-PHENYL)ACETIC ACID
C18H23N3O4 (345.16884780000004)
N-BOC-isoindoline-4-boronic acid, pinacol ester
C19H28BNO4 (345.21112780000004)
Ethyl 3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylate
methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate
C17H23N5O3 (345.18008080000004)
tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindoline-2-carboxylate
C19H28BNO4 (345.21112780000004)
4-[[4-[4-(hydroxymethyl)-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile
C20H19N5O (345.15895240000003)
Levomethadone hydrochloride
C21H28ClNO (345.18593080000005)
2-(1-(TERT-BUTOXYCARBONYL)-2,3-DIHYDROSPIRO[INDENE-1,4-PIPERIDIN]-3-YL)ACETIC ACID
C20H27NO4 (345.19399820000007)
Methadone hydrochloride
C21H28ClNO (345.18593080000005)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
Metipranolol Hydrochloride
C17H28ClNO4 (345.1706758000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist Metipranolol hydrochloride is a non-selective β adrenergic receptor blocking agent.
Eptapirone
C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Eptapirone (F11440) is a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Tretoquinol
C19H23NO5 (345.15761480000003)
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
Crisnatol
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
4-Tert-butyl-2-[(tert-butylamino)methyl]-6-(4-chlorophenyl)phenol
C21H28ClNO (345.18593080000005)
N-(1-naphthalenyl)-4-(phenylmethyl)-1-piperazinecarboxamide
Ethyl 2-[4-(carbamoylamino)-8-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate
C18H23N3O4 (345.16884780000004)
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
4-(1,3-benzodioxol-5-ylmethyl)-N-cyclohexylpiperazine-1-carboxamide
C19H27N3O3 (345.20523119999996)
1-benzyl-5-chloro-N-cycloheptyl-3-methyl-1H-pyrazole-4-carboxamide
L-Arginine, L-asparaginylglycyl-
Aspyridone B
C19H23NO5 (345.15761480000003)
2-Pyridone carrying as substituents a branched dimethylhexanoyl group, a hydroxy group and a 3,4-dihydroxyphenyl group at C-3, -4 and -5 respectively. Secondary metabolite produced by Aspergillus spp.
N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide
PF 750 is a selective and covalent fatty acid amide hydrolase (FAAH) inhibitor, with IC50s varied from 16.2-595 nM in different pre-incubation times. Covalently modifies the enzyme’s active site serine nucleophile[1].
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoate
A polyunsaturated fatty acid anion that is the conjugate base of (13R)-hydroxy-(7Z,10Z,14E,16Z,19Z)-docosapentaenoic acid, arising from deprotonation of the carboxylic acid group; major species at pH 7.3. It is an intermediate in 13-series resolvins biosynthesis from DPA (omega-3).
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]propanoyl]amino]hexanoic Acid
1-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)pyrrolidine-2,5-dione
C19H27N3O3 (345.20523119999996)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
4-[2-(2,6-Dimethyl-1-piperidinyl)-2-oxoethyl]-1-methyl-5-pyrrolo[3,2-b]pyrrolecarboxylic acid ethyl ester
C19H27N3O3 (345.20523119999996)
Leu-Val-Asp
A tripeptide composed of L-leucine, L-valine and L-aspartic acid joined in sequence by peptide linkages.
Glu-Val-Val
A tripeptide composed of L-glutamic acid and two L-valine units joined in sequence by peptide linkages.
3-[[2-(4-Methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester
C18H23N3O4 (345.16884780000004)
4-[[(4S)-2-amino-3-[2-(1-naphthalenyl)ethyl]-4,5-dihydroimidazol-4-yl]methyl]phenol
1-Tert-butyl-6-methyl-3-(1-naphthalenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine
2-phenyl-N-(3-(piperidin-1-yl)propyl)quinolin-4-amine
N-(cyclohexylmethyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine
N-(2-fluorophenyl)-3-[4-(2-fluorophenyl)-1-piperazinyl]propanamide
2-(2-methoxyethyl)-7-[oxo-(4-propyl-1-piperazinyl)methyl]-3H-isoindol-1-one
C19H27N3O3 (345.20523119999996)
4-methyl-N-(3-morpholin-4-ylpropyl)-3-(2-oxopyrrolidin-1-yl)benzamide
C19H27N3O3 (345.20523119999996)
(1S)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-2-oxido-3,4-dihydro-1H-isoquinolin-2-ium-7-ol
C19H23NO5 (345.15761480000003)
(2R,4S)-4-cyclohexyl-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-carboxamide
C20H27NO4 (345.19399820000007)
[1-(Cyclohexylmethyl)-3-piperidinyl]-(3,4-dimethoxyphenyl)methanone
(7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-7,10,13,16-tetraenoate
(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosa-4,7,10,13,16-pentaenoate
(7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-7,10,13-trienoate
(7Z,10Z)-12-{3-[(2Z,5Z)-octa-2,5-dien-1-yl]oxiran-2-yl}dodeca-7,10-dienoate
(7Z)-9-{3-[(2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl]oxiran-2-yl}non-7-enoate
2-{[1,1-bi(cyclohexyl)-1-ylcarbonyl]oxy}-N,N-diethylethanaminium chloride
C19H36ClNO2 (345.24344260000004)
3-[4-(acetyloxy)-2,3,5-trimethylphenoxy]-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride
C17H28ClNO4 (345.1706758000001)
N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide
C18H23N3O4 (345.16884780000004)
4-[[(1S,5R)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]oxazole
N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-4-carboxamide
C18H23N3O4 (345.16884780000004)
N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide
C18H23N3O4 (345.16884780000004)
N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide
C18H23N3O4 (345.16884780000004)
N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide
C18H23N3O4 (345.16884780000004)
N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide
C18H23N3O4 (345.16884780000004)
N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide
C18H23N3O4 (345.16884780000004)
N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide
C18H23N3O4 (345.16884780000004)
(2S,3R)-2-(hydroxymethyl)-6-(1-oxopropyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide
C19H27N3O3 (345.20523119999996)
(2S,3S)-2-(hydroxymethyl)-6-(1-oxopropyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide
C19H27N3O3 (345.20523119999996)
12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodecanoate
Sebacoyl-L-carnitine, analytical standard
C17H31NO6 (345.21512659999996)
(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosa-8,10,13,16,19-pentaenoate
11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoundecanoate
(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosa-4,7,10,12,16-pentaenoate
(10R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoundecanoate
(11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydodecanoate
DI-Tert-butyl 2-phenyl-1-pyrroline-trans-3,4-dicarboxylate
C20H27NO4 (345.19399820000007)
2-[4-[4-(4-Carbamimidoylphenyl)piperazin-1-yl]piperidin-1-yl]acetic acid
C18H27N5O2 (345.21646419999996)
O-sebacoylcarnitine
C17H31NO6 (345.21512659999996)
An O-acylcarnitine having sebacoyl as the acyl substituent.
(7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoate
A docosanoid anion that is the conjugate base of (7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3
(7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoate
A docosanoid anion that is the conjugate base of (7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoate
A docosanoid anion that is the conjugate base of (7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoate
A docosanoid anion that is the conjugate base of (7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate
A hydroxydocosapentaenoate that is the conjugate base of (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoic acid, arising from deprotonation of the carboxy group; major species at pH 7.3.
(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosapentaenoate
A hydroxydocosahexaenoate that is the conjugate base of (8E,10Z,13Z,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoate
A docosanoid anion that is the conjugate base of (4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
oscr#20(1-)
A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#20, obtained by deprotonation of the carboxy group; major species at pH 7.3.
TCS 46b
TCS 46b (Compound 46b) is a potent, selective and orally active NMDA NR1A/2B receptor antagonist with an IC50 of 5.3 nM[1]. TCS 46b is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde
(1r,2s,11r,12r,15s,16r,18r)-12-[(1s)-1-hydroxyethyl]-14,20-dioxa-6-azahexacyclo[16.2.1.0¹,⁶.0²,¹⁰.0²,¹⁶.0¹¹,¹⁵]henicos-9-en-13-one
C20H27NO4 (345.19399820000007)
(1s)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C20H27NO4 (345.19399820000007)
(1s,5s,6r,8r,9s,11r,13r,14s,15s,16r,17s,18s,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,13,15,19-tetrol
C20H27NO4 (345.19399820000007)
(2s)-1-{[(3r,3as,6ar,9ar,9bs)-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid
C20H27NO4 (345.19399820000007)
(7z)-5-methoxy-8-methyl-11-(6-methylhept-5-en-2-yl)-13-oxa-2-azatricyclo[8.2.1.0⁴,¹²]trideca-2,4(12),7-trien-3-ol
4,12,14-trihydroxy-5-isopropyl-6,9-dimethyl-15-azatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadeca-1,13(16),14-trien-3-one
C20H27NO4 (345.19399820000007)
3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde
(1r,3r,4s,5r,8r,9s,11s,13r,14s,16s,17r,18r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,4,13,18-tetrol
C20H27NO4 (345.19399820000007)
1-{[(3as,6ar,9ar,9bs)-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid
C20H27NO4 (345.19399820000007)
4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-6-ol
C20H27NO4 (345.19399820000007)
5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-4-ol
C20H27NO4 (345.19399820000007)
(2S)-1-[[(3R,3aS,6aR,9aR,9bS)-2-keto-6,9-dimethylene-3a,4,5,6a,7,8,9a,9b-octahydro-3H-azuleno[5,4-d]furan-3-yl]methyl]proline
C20H27NO4 (345.19399820000007)
{"Ingredient_id": "HBIN006567","Ingredient_name": "(2S)-1-[[(3R,3aS,6aR,9aR,9bS)-2-keto-6,9-dimethylene-3a,4,5,6a,7,8,9a,9b-octahydro-3H-azuleno[5,4-d]furan-3-yl]methyl]proline","Alias": "(2S)-1-[[(3R,3aS,6aR,9aR,9bS)-6,9-dimethylidene-2-oxo-3a,4,5,6a,7,8,9a,9b-octahydro-3H-azuleno[5,4-d]furan-3-yl]methyl]pyrrolidine-2-carboxylic acid; (2S)-1-[[(3R,3aS,6aR,9aR,9bS)-6,9-dimethylene-2-oxo-3a,4,5,6a,7,8,9a,9b-octahydro-3H-azuleno[5,4-d]furan-3-yl]methyl]-2-pyrrolidinecarboxylic acid; (2S)-1-[[(3R,3aS,6aR,9aR,9bS)-6,9-dimethylene-2-oxo-3a,4,5,6a,7,8,9a,9b-octahydro-3H-azuleno[5,4-d]furan-3-yl]methyl]pyrrolidine-2-carboxylic acid","Ingredient_formula": "C20H27NO4","Ingredient_Smile": "NA","Ingredient_weight": "345.43","OB_score": "20.90306639","CAS_id": "126209-82-3","SymMap_id": "SMIT10448","TCMID_id": "NA","TCMSP_id": "MOL009296","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-deoxycephalofortuneine
C20H27NO4 (345.19399820000007)
{"Ingredient_id": "HBIN013159","Ingredient_name": "7-deoxycephalofortuneine","Alias": "NA","Ingredient_formula": "C20H27NO4","Ingredient_Smile": "COC1CC23C(=CC1O)CCN2CCCC4=CC(=C(C=C34)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5159","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,2s,3s,5s,8r,9s,11s,13r,14s,16s,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,13,18-tetrol
C20H27NO4 (345.19399820000007)
(1s,17s)-5,6,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2,4,6,14-tetraen-4-ol
C20H27NO4 (345.19399820000007)
4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-16-ol
C20H27NO4 (345.19399820000007)
n-[2-(3,4-dihydroxyphenyl)ethyl]-2-[(1r,2r)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethanimidic acid
C20H27NO4 (345.19399820000007)
3-[(2r,5s)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid
C19H27N3O3 (345.20523119999996)
(1's,3s,3's,7's)-1,4',4',14'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,13'-trione
C19H27N3O3 (345.20523119999996)
(1s,3s,5r,8s,9r,10s,11r,14r,16s,17r,18s,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,9,10,19-tetrol
C20H27NO4 (345.19399820000007)
5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,13,15,19-tetrol
C20H27NO4 (345.19399820000007)
(1r,9s,10s,12r)-4,5,12-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-13-one
C20H27NO4 (345.19399820000007)
(3r)-3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde
(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylbutylidene]amino}butanedioic acid
methyl 5-ethyl-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate
(2r)-1-{[(3r,3as,6ar,9ar,9bs)-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid
C20H27NO4 (345.19399820000007)
(3s)-3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde
(1'r,3s,3's,7's,12's)-13'-hydroxy-1,4',4',12'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,5-dione
C19H27N3O3 (345.20523119999996)
(2e,7e)-tetradeca-2,7-dien-1-yl 4-amino-3-hydroxybenzoate
3-[(2s,5r)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid
C19H27N3O3 (345.20523119999996)
octahydro-1h-quinolizin-1-ylmethyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C20H27NO4 (345.19399820000007)
5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,4,13,18-tetrol
C20H27NO4 (345.19399820000007)
4,5,12-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-13-one
C20H27NO4 (345.19399820000007)
(2e)-4-[(2s,3r,5r,6s)-6-[2-(4-aminophenyl)-2-oxoethyl]-3,5-dimethyloxan-2-yl]pent-2-enoic acid
C20H27NO4 (345.19399820000007)
(2s,5s,10r,13s,14s,17s,18s)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-14,18-diol
(2s,3s,5r,6r,9s,11s,16r,17s,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18-tetrol
C20H27NO4 (345.19399820000007)
(1s,16s,17r)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-16-ol
C20H27NO4 (345.19399820000007)
5,6,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2,4,6,14-tetraen-4-ol
C20H27NO4 (345.19399820000007)
7-chloro-3-(7-hydroxy-2-methylhepta-2,4-dien-1-yl)-1-methyl-hexahydro-2h-indolizine-1,2,8-triol
C17H28ClNO4 (345.1706758000001)
3-[(2r,5r)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid
C19H27N3O3 (345.20523119999996)
5-hydroxy-4',4',12',14'-tetramethyl-4h-9',14'-diazaspiro[pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,13'-dione
C19H27N3O3 (345.20523119999996)
(2s)-1-{[(3as)-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid
C20H27NO4 (345.19399820000007)
(3e,7e)-n-(3,4-dihydroxybutyl)-2,6,9-trihydroxy-4,8-dimethylundeca-3,7-dienimidic acid
C17H31NO6 (345.21512659999996)
13'-hydroxy-1,4',4',12'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,5-dione
C19H27N3O3 (345.20523119999996)
4,5,6-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-17-ol
C20H27NO4 (345.19399820000007)
5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,6,10,19-tetrol
C20H27NO4 (345.19399820000007)
(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C20H27NO4 (345.19399820000007)
4-{6-[2-(4-aminophenyl)-2-oxoethyl]-3,5-dimethyloxan-2-yl}pent-2-enoic acid
C20H27NO4 (345.19399820000007)
3-[3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid
C19H27N3O3 (345.20523119999996)
5,9-dimethoxy-14-methyl-7-oxa-14-azapentacyclo[9.6.2.0¹,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11(19)-trien-4-ol
C20H27NO4 (345.19399820000007)
(1s,17s)-4,5,6-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-17-ol
C20H27NO4 (345.19399820000007)
3-[(2s,5s)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid
C19H27N3O3 (345.20523119999996)
(4r,5r,6r,9r,12s)-4,12,14-trihydroxy-5-isopropyl-6,9-dimethyl-15-azatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadeca-1,13(16),14-trien-3-one
C20H27NO4 (345.19399820000007)
(1s,2s,3s,7s,8s,8ar)-7-chloro-3-[(2z,4e)-7-hydroxy-2-methylhepta-2,4-dien-1-yl]-1-methyl-hexahydro-2h-indolizine-1,2,8-triol
C17H28ClNO4 (345.1706758000001)
n-[2-(3,4-dihydroxyphenyl)ethyl]-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethanimidic acid
C20H27NO4 (345.19399820000007)
(1r,16r,19s,21r)-16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde
n-(3,4-dihydroxybutyl)-2,8,9-trihydroxy-4,8-dimethylundeca-3,6-dienimidic acid
C17H31NO6 (345.21512659999996)
8-ethoxy-4,5-dimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6,12-tetraene
C20H27NO4 (345.19399820000007)
(1r,4r,5s,14s)-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-4-ol
C20H27NO4 (345.19399820000007)
(1s,3r,5r,6s,8r,9s,10s,11r,14r,16s,17s,18r,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,6,10,19-tetrol
C20H27NO4 (345.19399820000007)
(1s,2s,3s,7s,8s,8ar)-7-chloro-3-[(2e,4e)-7-hydroxy-2-methylhepta-2,4-dien-1-yl]-1-methyl-hexahydro-2h-indolizine-1,2,8-triol
C17H28ClNO4 (345.1706758000001)
1-({6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl}methyl)pyrrolidine-2-carboxylic acid
C20H27NO4 (345.19399820000007)
(1'r,3s,3's,7's,12's)-5-hydroxy-4',4',12',14'-tetramethyl-4h-9',14'-diazaspiro[pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,13'-dione
C19H27N3O3 (345.20523119999996)
(3as,6ar,8s,9ar,9bs)-3,6,9-trimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-8-yl (2s)-2-amino-3-methylbutanoate
C20H27NO4 (345.19399820000007)
(2s)-n-[(2s)-1-(acetyloxy)-3-(1h-indol-3-yl)propan-2-yl]-3-methyl-2-(methylamino)butanimidic acid
C19H27N3O3 (345.20523119999996)
1,4',4',14'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,13'-trione
C19H27N3O3 (345.20523119999996)
(1r,2s,3s,5s,6r,8r,9s,11s,14s,16s,17s,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18-tetrol
C20H27NO4 (345.19399820000007)
({[(3s)-6-amino-3-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyhexylidene]amino}(methyl)amino)acetic acid
(1s,8s,10r,17s)-8-ethoxy-4,5-dimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6,12-tetraene
C20H27NO4 (345.19399820000007)
(7s,7ar)-1-({[(2r)-2,3-dihydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate
n-(3,4-dihydroxybutyl)-2,6,9-trihydroxy-4,8-dimethylundeca-3,7-dienimidic acid
C17H31NO6 (345.21512659999996)
6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}-2-[(1-hydroxyethylidene)amino]hexanoic acid
C18H23N3O4 (345.16884780000004)
(3e,6e)-n-(3,4-dihydroxybutyl)-2,8,9-trihydroxy-4,8-dimethylundeca-3,6-dienimidic acid
C17H31NO6 (345.21512659999996)
(1r,3r,4r,5r,8r,9s,11s,13r,14s,16s,17r,18r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,4,13,18-tetrol
C20H27NO4 (345.19399820000007)
(1s,17s)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-6-ol
C20H27NO4 (345.19399820000007)
(2s)-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}-2-[(1-hydroxyethylidene)amino]hexanoic acid
C18H23N3O4 (345.16884780000004)
[({6-amino-3-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1-hydroxyhexylidene}amino)(methyl)amino]acetic acid
(1s,16s,19r,21s)-16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde
(2r,3r)-3-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-phenoxybutan-2-ol
C20H27NO4 (345.19399820000007)
methyl (1r,2r,5s,8s,14r,15r)-5-ethyl-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate
12-hydroxy-12-(hydroxymethyl)-5,7-dimethyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-11-one
3,6,9-trimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-8-yl 2-amino-3-methylbutanoate
C20H27NO4 (345.19399820000007)